why choose us

First received: September 26, 2022

Clinical Trial: Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Study Status: Completed

Recruit Status: RECRUITING

Condition: Multiple Myeloma

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Randomized, Open-Label Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergo

Brief Summary: This is a randomized, open-label study.Patients will be screened within 28 days prior to the study drug administration.Patients will be randomly assigned to 1 of 2 treatment arms prior to study drug administration.Approximately 40 patients will be randomized in a 1:1 ratio to the following treatment arms:GPC-100 in combination with propranolol; orGPC-100 in combination with propranolol and G-CSF.To characterize the safety and clinical activity of GPC-100, the study will employ a Bayesian Optimal Phase II (BOP2)…

Read more